D-Dimer

D-dimers are fibrin degradation products which are released during local or systemic activation of coagulation. The presence of D-dimers indicates that a fibrin clot was formed and subsequently degraded by plasmin. D-dimer is present whenever the coagulation system has been activated with clot formation, followed by fibrinolysis. D-dimer testing is widely used for the work-up of patients suspected of deep vein thrombosis (DVT) or pulmonary embolism (PE). In addition, when combined with other tests of coagulation, D-dimer testing is useful in the diagnosis of disseminated intravascular coagulation (DIC).

Increased levels of D-Dimer have been reported in the following: DIC, DVT, pulmonary embolism, surgery, cancer, and liver cirrhosis due to decreased hepatic clearance. D-Dimer is a useful test in the differential diagnosis of DIC. The presence of significantly increased D-Dimer levels differentiates DIC from primary fibrinolysis, where the level is not increased. In DIC, both thrombin and plasmin are generated causing an elevation in D-dimers. D-dimer assay is a very sensitive test for DIC, DVT, and PE. The D-dimer can be measured by a variety of methods: semi-quantitative vs. quantitative, manual vs. automated, latex agglutination vs. ELISA.

The newly developed highly sensitive automated D-dimer tests may be used to exclude PE and DVT: a negative test essentially rules out thrombosis, but a positive test does not confirm the diagnosis, and correlation with clinical findings and possible further testing (e.g., ultrasound) is recommended.

  • In diagnosis of disseminated intravascular coagulation
  • In diagnosis of deep vein thrombosis and pulmonary embolism
  • To monitor therapy in DIC or DVT
  • Other thromboembolic disorders (stroke)

Increased in:

  • Deep vein thrombosis
  • Disseminated intravascular coagulation (DIC)
  • Pulmonary embolism
  • Arterial thromboembolism
  • Other embolic disorder (stroke), pregnancy (postpartum period), malignancy, surgery, thrombolytic therapy

<0.5μg/mL

 

 

Latex agglutination assay, Enzyme Linked immunosorbent assay (ELISA)

Plasma Citrate (Light Blue)

Freeze immediately and maintain frozen until tested.

Stability

  • Ambient: Unacceptable
  • Refrigerated: Unacceptable
  • Frozen: 14 days
Prothrombin time (PT) with INR, Activated Partial Thromboplastin Time (APTT), Fibrinogen, Platelet Count, Erythrocyte Sedimentation Rate.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login